Reactive infectious mucocutaneous eruption: A distinct clinical entity in the post-COVID-19 era

Abstract

Dear Editor, I am writing this letter to highlight the clinical significance of Reactive Infectious Mucocutaneous Eruption (RIME), an increasingly recognized post-infectious syndrome that remains underdiagnosed, particularly in adult patients. Given its overlapping features with severe mucocutaneous conditions such as Stevens-Johnson syndrome (SJS), timely identification of RIME is crucial for appropriate management and prevention of unnecessary interventions. This correspondence aims to summarize current knowledge on RIME and emphasize the importance of a multidisciplinary approach in its diagnosis and treatment.